BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 812568)

  • 21. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
    Beutler E; Kuhl W; Comings D
    Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different gene mutations in variants of GM1- and GM2- gangliosidosis demonstrated by enzyme analysis of (single) somatic hybrid cells.
    Galjaard H; Hoogeveen A; Keijzer W; de Wit-Verbeek HA; Reuser AJ
    Birth Defects Orig Artic Ser; 1975; 11(3):150-6. PubMed ID: 812565
    [No Abstract]   [Full Text] [Related]  

  • 23. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
    Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
    Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
    [No Abstract]   [Full Text] [Related]  

  • 24. Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization.
    Galjaard H; Hoogeveen A; de Wit-Verbeek HA; Reuser AJ; Keijzer W; Westerveld A; Bootsma D
    Exp Cell Res; 1974 Aug; 87(2):444-8. PubMed ID: 4416048
    [No Abstract]   [Full Text] [Related]  

  • 25. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segregation within a family of two mutant alleles for hexosaminidase A.
    Kelly TE; Reynolds LW; O'Brien JS
    Clin Genet; 1976 May; 9(5):540-3. PubMed ID: 1269177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.
    Gilbert F; Kucherlapati R; Creagan RP; Murnane MJ; Darlington GJ; Ruddle FH
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):263-7. PubMed ID: 1054503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetyl-beta-hexosaminidase: role in the degradation of glycosaminoglycans.
    Thompson JN; Stoolmiller AC; Matalon R; Dorfman A
    Science; 1973 Aug; 181(4102):866-7. PubMed ID: 4269276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to the control and prevention of Tay-Sachs disease.
    Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
    Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different gene mutations in variants of GM1- and GM2-gangliosidosis demonstrated by enzyme analysis of (single) somatic hybrid cells.
    Galjaard H; Hoogeveen A; Keijzer W; de Wit-Verbeek HA; Reuser AJ
    Cytogenet Cell Genet; 1975; 14(3-6):320-6. PubMed ID: 1192809
    [No Abstract]   [Full Text] [Related]  

  • 31. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
    Yuasa T; Fukuma M; Takashima S; Takaki R
    Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hexosaminidase A analysis of various biological fluids by pH inactivation for the identification of Tay-Sachs disease genotypes.
    Saifer A; Perle G
    Prog Clin Biol Res; 1977; 18():227-38. PubMed ID: 23555
    [No Abstract]   [Full Text] [Related]  

  • 33. Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts.
    d'Azzo A; Halley DJ; Hoogeveen A; Galjaard H
    Am J Hum Genet; 1980 Jul; 32(4):519-28. PubMed ID: 6772024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic heterogeneity of the hexosaminidase deficiency diseases.
    Johnson WG
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():215-37. PubMed ID: 6337393
    [No Abstract]   [Full Text] [Related]  

  • 35. Complementation studies with enucleated fibroblasts from different variants of beta-galactosidase deficiency.
    de Wit-Verbeek HA; Hoogeveen A; Galjaard H
    Exp Cell Res; 1978 Apr; 113(1):215-8. PubMed ID: 416963
    [No Abstract]   [Full Text] [Related]  

  • 36. Tay-Sachs disease: ultrastructural studies on cultured fibroblasts.
    Wyatt PR; Cox DM; Hoogstraten J
    Pediatr Res; 1978 Apr; 12(4 Pt 1):310-3. PubMed ID: 652414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of beta-D-N-acetylhexosaminidases C and S in fibroplasts from control individuals and patients with Tay-Sachs disease.
    Reuser AJ; Galjaard H
    FEBS Lett; 1976 Nov; 72(1):1-5. PubMed ID: 11130
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary hexosaminidase analysis for the identification of Tay-Sachs genotypes.
    Saifer A; Amoroso J; Perle G
    Clin Chim Acta; 1976 Mar; 67(3):315-9. PubMed ID: 4244
    [No Abstract]   [Full Text] [Related]  

  • 40. Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease.
    Navon R; Padeh B; Adam A
    Am J Hum Genet; 1973 May; 25(3):287-93. PubMed ID: 4704860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.